The mechanism of action of tissue plasminogen activator is
Inhibits platelet aggregation
Enhance fibrin degradation
Inhibit clot formation
Tissue Plasminogen Activator (tPA) is a serine protease involved in the breakdown of blood clots. It plays a vital role in the thrombolytic or fibrinolytic process, helping to convert plasminogen to plasmin. Plasmin is an enzyme that breaks down fibrin, a protein involved in blood clotting. Therefore, tPA enhances fibrin degradation.
Here's how it works:
This mechanism highlights the thrombolytic function of tPA, primarily used in clinical settings to treat acute ischemic strokes, myocardial infarctions, and pulmonary embolisms by dissolving the clots that block blood flow. Thus, the correct answer to the question regarding tPA's mechanism of action is:
Other options such as "Inhibit extrinsic pathway," "Inhibits platelet aggregation," and "Inhibit clot formation" do not accurately describe the primary mechanism of action of tPA.
Which of the following is true regarding the image provided?
A patient presents with painful vesicles in the genital region. Identify the lesion shown in the image and choose the correct diagnosis.
A 30-year-old patient presents with a history of flat lesions near the anal canal, rashes on the body, and hair loss that follows a particular pattern, as shown in the image. What is the diagnosis?
A patient presents with no pulse, and the ECG shows the following rhythm. What is the next appropriate step?
Identify the arrow-marked nerve.